multiomics
U of Southampton to Use ClearNote Health Test in Large-Scale Pancreatic Cancer Surveillance Study
The epigenetic test will look for signs of pancreatic cancer among adults newly diagnosed with type 2 diabetes in a trial that aims to enroll up to 15,000 participants.
Owkin Expands Into Western Europe With Nine Precision Medicine Partnerships
The firm will employ its machine learning-enabled diagnostic and drug discovery tools in nine centers across Germany, Austria, and Switzerland.
Evotec Strikes Metabolic Disease Research Alliance With Inserm, Lille University Hospital
Evotec will use samples from an ongoing clinical trial of obesity to generate omics data that can provide insights into the etiology of various metabolic diseases.
Wellcome Sanger Institute, Open Targets Fund Inflammatory Bowel Disease Biomarker Study
Researchers will analyze multiomic and clinical data from 1,000 patients with IBD recruited from seven participating hospitals in the UK.
White House Unveils ADAPT Program to Advance Biomarker-Guided Cancer Treatment
As part of ARPA-H, ADAPT will fund research into biomarker strategies that adapt to changing tumor biology and ways to translate them into clinical trials.